Featured Research

from universities, journals, and other organizations

New Alzheimer’s Treatment Under Study At Medical College Of Georgia

Date:
July 2, 2004
Source:
Medical College Of Georgia
Summary:
A new drug that appears to improve learning and memory in animals and may reduce the accumulation of destructive plaque that is the hallmark of Alzheimer’s disease is under study at the Medical College of Georgia.

Dr. Jeffrey L. Rausch is enrolling patients in an international trial of a new treatment for Alzheimer's disease.
Credit: Photo courtesy of Medical College Of Georgia

A new drug that appears to improve learning and memory in animals and may reduce the accumulation of destructive plaque that is the hallmark of Alzheimer’s disease is under study at the Medical College of Georgia.

MCG is enrolling Alzheimer’s patients with mild to moderate memory loss in a 12-week study that compares different doses of the drug - still known only by a number - to placebo. The study is being conducted at approximately 40 sites worldwide, including 34 sites in the United States.

“We want to see if this drug will improve cognition or memory in Alzheimer’s disease,” said Dr. Jeffrey L. Rausch, psychiatrist, vice chair of the MCG Department of Psychiatry and Health Behavior and a principal investigator on the study.

The drug, developed by Sanofi-Synthelabo, Inc., in France, has been shown in published studies to improve episodic memory (using an object recognition task) and to reverse learning decline in aging rats, Dr.Rausch said.

Previous clinical trials have suggested the drug is safe in humans; the current study will look at its efficacy and safety.

The drug is among the first to target 5HT4 receptors, one of the numerous receptors that regulates serotonin, a neurotransmitter that enables cells to communicate. Patients with clinical depression often have too little serotonin activity. Many antidepressants work by maximizing the serotonin patients do have.

Although there is no evidence that Alzheimer’s disease directly affects 5HT4 receptors, there is some common ground. 5HT4 activity is associated with an increased excretion of a soluble form of the amyloid precursor protein sAPPá.

However, the insoluble form of this protein deposits in plaques in the brains of Alzheimer’s patients. “Stimulation of the 5HT4 receptors appears to be neuroprotective and memory enhancing in animals,” Dr. Rausch says. Soluble amyloid protein, which can move easily around cells without getting stuck, has antioxidant properties for scavenging free radicals and other potentially destructive trash in the brain.

The new drug under study appears to have a synergistic action with acetylcholinesterase (AChE) inhibitors, which are used to treat symptoms of Alzheimer's disease and which regulate the acetylcholine system, a major neurotransmitter system. A progressive loss of acetylcholine is considered a major culprit in the memory loss that accompanies Alzheimer's; some of the Alzheimer’s drugs already on the market also work to increase acetylcholine, Dr. Rausch said.

This new drug stimulates 5HT4 receptors which are critical to memory and adaptation to the environment. Dr. Rausch noted that Alzheimer’s patients often become irritable and inflexible as their disease progresses, functioning best in a familiar environment and often unable to adjust to a new one. “If you put them in a new environment, their ability to learn and adapt to new things is not there and you may see more dysfunction,” he said.

“We hope this new drug, which is among the first to target this particular serotonin receptor, will indicate a new way of treating this devastating disease,” Dr. Rausch said. “If the study finds the drug successful, perhaps it can one day be used to delay disease progression until a cure for Alzheimer’s can be found.”

For more information about the study, call coordinator Kay Bingham at (706) 721-7835.


Story Source:

The above story is based on materials provided by Medical College Of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College Of Georgia. "New Alzheimer’s Treatment Under Study At Medical College Of Georgia." ScienceDaily. ScienceDaily, 2 July 2004. <www.sciencedaily.com/releases/2004/07/040701084400.htm>.
Medical College Of Georgia. (2004, July 2). New Alzheimer’s Treatment Under Study At Medical College Of Georgia. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2004/07/040701084400.htm
Medical College Of Georgia. "New Alzheimer’s Treatment Under Study At Medical College Of Georgia." ScienceDaily. www.sciencedaily.com/releases/2004/07/040701084400.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) — West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) — A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) — Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) — Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins